{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:05:17Z","timestamp":1762527917439,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ajoc.2022.101501","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:42:03Z","timestamp":1648208523000},"page":"101501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["\u201cRapid and reversible alteration in corneal contour and power associated with Netarsudil\/Latanoprost\u201d"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8686-8147","authenticated-orcid":false,"given":"David","family":"Chung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward J.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajoc.2022.101501_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40265-018-0877-7","article-title":"Netarsudil ophthalmic solution 0.02%: first global approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"issue":"1-2","key":"10.1016\/j.ajoc.2022.101501_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/jop.2017.0023","article-title":"Discovery and preclinical development of netarsudil, a novel ocular hypotensive agent for the treatment of glaucoma","volume":"34","author":"Lin","year":"2018","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101501_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1089\/jop.2017.0138","article-title":"The effects of netarsudil ophthalmic solution on aqueous humor dynamics in a randomized study in humans","volume":"34","author":"Kazemi","year":"2018","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"14","key":"10.1016\/j.ajoc.2022.101501_bib4","doi-asserted-by":"crossref","first-page":"6197","DOI":"10.1167\/iovs.16-20189","article-title":"Netarsudil increases outflow facility in human eyes through multiple mechanisms","volume":"57","author":"Ren","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101501_bib5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00417-020-04691-y","article-title":"Dose-dependent effects of netarsudil, a Rho-kinase inhibitor, on the distal outflow tract","volume":"258","author":"Chen","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101501_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajo.2020.04.002","article-title":"Reticular bullous epithelial edema in corneas treated with netarsudil: a case series","volume":"217","author":"Wisely","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101501_bib7","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/IJG.0000000000001507","article-title":"Reversible corneal endothelial abnormalities with netarsudil","volume":"29","author":"Tanna","year":"2020","journal-title":"J Glaucoma"},{"issue":"7","key":"10.1016\/j.ajoc.2022.101501_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/IJG.0000000000001516","article-title":"Reticular corneal edema or corneal honeycombing in eyes treated with netarsudil: a case series","volume":"29","author":"Moumneh","year":"2020","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajoc.2022.101501_bib9","doi-asserted-by":"crossref","first-page":"100800","DOI":"10.1016\/j.ajoc.2020.100800","article-title":"Netarsudil-associated epithelial keratopathy","volume":"19","author":"Ramakrishnan","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101501_bib10","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.ophtha.2018.08.004","article-title":"Reticular epithelial edema in edematous corneas treated with netarsudil","volume":"125","author":"Fernandez","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101501_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ogla.2019.01.001","article-title":"Netarsudil-associated reticular corneal epithelial edema with raised intraocular pressure","volume":"2","author":"Liu","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"issue":"8","key":"10.1016\/j.ajoc.2022.101501_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/jamaophthalmol.2020.1023","article-title":"A patient with glaucoma with corneal edema","volume":"138","author":"Chen","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajoc.2022.101501_bib13","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1097\/IJG.0000000000001636","article-title":"Reticular epithelial edema: an uncommon side effect of ROCK\/NET inhibitor netarsudil","volume":"29","author":"Chen","year":"2020","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajoc.2022.101501_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ajo.2017.11.019","article-title":"Two phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure: rho kinase elevated IOP treatment trial 1 and 2 (ROCKET-1 and ROCKET-2)","volume":"186","author":"Serle","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101501_bib15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajo.2019.01.003","article-title":"Long-term safety and ocular hypotensive efficacy evaluation of netarsudil ophthalmic solution: rho kinase elevated IOP treatment trial (ROCKET-2)","volume":"200","author":"Kahook","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101501_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ajo.2019.03.002","article-title":"Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized phase 3 ROCKET-4 study","volume":"204","author":"Khouri","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2022.101501_bib17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ogla.2020.04.014","article-title":"Effects of netarsudil on the corneal endothelium: three-month findings from a phase 3 trial","volume":"3","author":"Mundorf","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ajoc.2022.101501_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ajo.2019.06.016","article-title":"Netarsudil\/latanoprost fixed-dose combination for elevated intraocular pressure: three-month data from a randomized phase 3 trial","volume":"207","author":"Asrani","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101501_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ogla.2020.05.008","article-title":"One year of netarsudil and latanoprost fixed-dose combination for elevated intraocular pressure: phase 3, randomized MERCURY-1 study","volume":"3","author":"Brubaker","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101501_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ogla.2019.03.007","article-title":"Once-daily netarsudil\/latanoprost fixed-dose combination for elevated intraocular pressure in the randomized phase 3 MERCURY-2 study","volume":"2","author":"Walters","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101501_bib21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s12325-020-01227-y","article-title":"Effects of netarsudil and latanoprost alone and in fixed combination on corneal endothelium and corneal thickness: post-hoc analysis of MERCURY-2","volume":"37","author":"Wisely","year":"2020","journal-title":"Adv Ther"},{"issue":"10","key":"10.1016\/j.ajoc.2022.101501_bib22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/archopht.1994.01090220048022","article-title":"Results of the prospective evaluation of radial keratotomy (PERK) study 10 years after surgery","volume":"112","author":"Waring","year":"1994","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2022.101501_bib23","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0886-3350(99)00090-5","article-title":"Diurnal fluctuations in corneal topography 10 years after radial keratotomy in the prospective evaluation of radial keratotomy study","volume":"25","author":"Kemp","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajoc.2022.101501_bib24","first-page":"1727","article-title":"A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma","volume":"18","author":"Yamamoto","year":"2012","journal-title":"Mol Vis"},{"issue":"15","key":"10.1016\/j.ajoc.2022.101501_bib25","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1167\/iovs.16-20123","article-title":"Activation of the rho\/rho kinase signaling pathway is involved in cell death of corneal endothelium","volume":"57","author":"Okumura","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2022.101501_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ajo.2021.03.006","article-title":"Randomized, double-masked, pilot study of netarsudil 0.02% ophthalmic solution for treatment of corneal edema in Fuchs dystrophy","volume":"227","author":"Price","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2022.101501_bib27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0161-6420(86)33765-5","article-title":"Diurnal change in refraction, corneal curvature, visual acuity, and intraocular pressure after radial keratotomy in the PERK Study","volume":"93","author":"Schanzlin","year":"1986","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101501_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.1992.01080150049026","article-title":"Diurnal variation of corneal topography after radial keratotomy","volume":"110","author":"Kwitko","year":"1992","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101501_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155527","article-title":"Changes in corneal biomechanical properties after long-term topical prostaglandin therapy","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362200247X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362200247X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:00:01Z","timestamp":1762527601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245199362200247X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":29,"alternative-id":["S245199362200247X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101501","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cRapid and reversible alteration in corneal contour and power associated with Netarsudil\/Latanoprost\u201d","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101501"}}